TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 36 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $965,000 | +4.0% | 987,000 | 0.0% | 0.13% | +20.7% |
| Q1 2020 | $928,000 | -1.2% | 987,000 | 0.0% | 0.11% | +42.3% |
| Q4 2019 | $939,000 | +4.8% | 987,000 | 0.0% | 0.08% | +9.9% |
| Q3 2019 | $896,000 | +0.3% | 987,000 | +1.2% | 0.07% | -10.1% |
| Q2 2019 | $893,000 | -1.2% | 975,000 | 0.0% | 0.08% | -7.1% |
| Q1 2019 | $904,000 | -60.2% | 975,000 | -61.0% | 0.08% | -65.3% |
| Q4 2018 | $2,270,000 | -3.6% | 2,503,000 | 0.0% | 0.24% | +20.1% |
| Q3 2018 | $2,354,000 | +1.5% | 2,503,000 | 0.0% | 0.20% | +10.3% |
| Q2 2018 | $2,320,000 | +5.2% | 2,503,000 | 0.0% | 0.18% | +30.3% |
| Q1 2018 | $2,206,000 | -77.6% | 2,503,000 | -77.6% | 0.14% | -75.5% |
| Q4 2017 | $9,843,000 | -87.3% | 11,153,000 | -87.0% | 0.58% | -85.3% |
| Q3 2017 | $77,368,000 | -21.8% | 85,608,000 | -6.8% | 3.96% | -23.3% |
| Q2 2017 | $98,950,000 | +0.3% | 91,833,000 | -0.3% | 5.16% | -1.0% |
| Q1 2017 | $98,636,000 | -7.6% | 92,133,000 | -4.4% | 5.21% | +2.4% |
| Q4 2016 | $106,728,000 | -6.7% | 96,368,000 | +0.6% | 5.09% | -3.6% |
| Q3 2016 | $114,365,000 | -4.3% | 95,823,000 | +0.9% | 5.28% | -4.8% |
| Q2 2016 | $119,448,000 | -1.3% | 94,943,000 | +1.7% | 5.55% | -2.8% |
| Q1 2016 | $121,059,000 | -7.3% | 93,388,000 | +12.0% | 5.71% | -6.9% |
| Q4 2015 | $130,650,000 | +16.0% | 83,413,000 | +0.9% | 6.13% | +17.9% |
| Q3 2015 | $112,594,000 | -12.3% | 82,638,000 | -9.8% | 5.20% | -4.0% |
| Q2 2015 | $128,322,000 | -14.2% | 91,577,000 | -9.1% | 5.42% | -23.5% |
| Q1 2015 | $149,528,000 | -9.4% | 100,692,000 | -16.5% | 7.08% | +5.1% |
| Q4 2014 | $165,074,000 | +4.0% | 120,547,000 | -2.3% | 6.74% | +9.4% |
| Q3 2014 | $158,700,000 | +0.5% | 123,382,000 | +0.6% | 6.16% | -1.4% |
| Q2 2014 | $157,856,000 | +8.1% | 122,602,000 | +7.6% | 6.24% | +22.3% |
| Q1 2014 | $146,038,000 | +17.4% | 113,932,000 | -2.1% | 5.11% | +14.2% |
| Q4 2013 | $124,357,000 | +2.4% | 116,357,000 | -0.4% | 4.47% | +9.6% |
| Q3 2013 | $121,479,000 | -4.8% | 116,807,000 | -4.0% | 4.08% | +8.3% |
| Q2 2013 | $127,644,000 | – | 121,612,000 | – | 3.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 83,413,000 | $130,650,000 | 6.13% |
| AEGON USA Investment Management, LLC | 6,000,000 | $9,368,000 | 2.35% |
| MACKAY SHIELDS LLC | 24,370,000 | $38,152,000 | 2.07% |
| INCOME RESEARCH & MANAGEMENT | 4,374,000 | $6,829,000 | 1.11% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 20,000 | $20,347,000 | 0.99% |
| SHENKMAN CAPITAL MANAGEMENT INC | 5,269,000 | $8,264,000 | 0.82% |
| Mitsubishi UFJ Securities Holdings Co., Ltd. | 325,000 | $511,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,299,000 | $14,598,000 | 0.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 14,543,000 | $23,021,000 | 0.35% |
| CSS LLC/IL | 3,750,000 | $5,893,000 | 0.35% |